tirzepatide fda changes says shortage is over after taking a second look June/July 2026 Changes to Tirzepatide

Patients treated with semaglutide (Ozempic / Wegovy) showed a 50% or greater reduction in the likelihood of both new alcohol use disorder (AUD) compared to patients treated with non GLP-1 anti-obesity or diabetes medications

4.2.1 Technical and engineering challenges Achieving a stable, reliable, and long-term intra-articular PBM system presents a complex biomedical engineering challenge

Poor Coordination : Tasks that require fine motor skills, such as buttoning a shirt or walking in a straight line, become more difficult

Why Consider Making the Switch

Where the evidence is already solid Beyond diabetes and obesity, GLP-1 drugs have now earned regulatory approval in several new areas